AN INDIVIDUALIZED APPROACH TO TREATMENT-RESISTANT BIPOLAR DISORDER: A CASE SERIES

被引:2
|
作者
Gurevich, Michael I. [1 ]
Robinson, Cassandra L. [2 ]
机构
[1] Glen Head, 997 Glen Cove Ave, Glen Head, NY 11545 USA
[2] Natl Coll Nat Med, Helfgott Res Inst, 2220 SW 1st Ave, Portland, OR 97201 USA
关键词
holistic medicine; integrative medicine; bipolar disorder; COMORBIDITY SURVEY REPLICATION; WEEKLY SYMPTOMATIC STATUS; DISCONTINUATION SYNDROME; ALTERNATIVE MEDICINE; SPECTRUM DISORDER; NATURAL-HISTORY; COMPLEMENTARY; PREVALENCE; DEPRESSION; THERAPIES;
D O I
10.1016/j.explore.2016.04.001
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Context: Treatment-resistant bipolar disorder (TRBD) is an increasingly prevalent, debilitating condition with substandard treatment outcomes. Polypharmacy has become the mainstay among practitioners though long-term efficacy of this method has not been adequately tested. Objective: Determine retrospectively if individualized, integrative treatment strategies applied while withdrawing pharmaceuticals were beneficial and safe among a TRBD clinic population. Design: A chart review was performed for six adult patients, treated in a private psychiatric practice. Data were collected regarding psychiatric diagnosis, hospitalizations, medications, side effects, substance abuse, and applied treatments. Results: Using individualized, integrative psychiatric treatment methods, the majority of medications were eliminated. Long-term remission was attained in all cases, defined as clinical stability with no discemable symptoms of bipolar disorder for at least one year. Conclusions: Applying an integrative treatment approach, and eliminating most medications, provided lasting resolution of symptoms and side effects in a selected sample of TRBD outpatients. These data may provide the basis for future randomized, controlled trials.
引用
收藏
页码:237 / 245
页数:9
相关论文
共 50 条
  • [1] Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder - A case series
    de Macedo-Soares, MB
    Moreno, RA
    Rigonatti, SP
    Lafer, B
    [J]. JOURNAL OF ECT, 2005, 21 (01) : 31 - 34
  • [2] Treatment-resistant bipolar disorder
    M Gitlin
    [J]. Molecular Psychiatry, 2006, 11 : 227 - 240
  • [3] Treatment-resistant bipolar disorder
    Gitlin, M
    [J]. MOLECULAR PSYCHIATRY, 2006, 11 (03) : 227 - 240
  • [4] Treatment-resistant bipolar disorder
    Gitlin, MJ
    [J]. BULLETIN OF THE MENNINGER CLINIC, 2001, 65 (01) : 26 - 40
  • [5] Use of asenapine in a case of treatment-resistant bipolar disorder
    Kohli, Sarabjeet
    Singh, Vinod
    [J]. PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2013, 17 (06) : 7 - 8
  • [6] Mexiletine in treatment-resistant bipolar disorder
    Schaffer, A
    Levitt, AJ
    Joffe, RT
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2000, 57 (1-3) : 249 - 253
  • [7] Olanzapine in treatment-resistant bipolar disorder
    McElroy, SL
    Frye, M
    Denicoff, K
    Altshuler, L
    Nolen, W
    Kupka, R
    Suppes, T
    Keck, PE
    Leverich, GS
    Kmetz, GF
    Post, RM
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 1998, 49 (02) : 119 - 122
  • [8] Clozapine for treatment-resistant bipolar disorder
    Vasiliu, Octavian
    [J]. BIPOLAR DISORDERS, 2023, 25 : 84 - 84
  • [9] Donepezil in treatment-resistant bipolar disorder
    Burt, T
    Sachs, GS
    Demopulos, C
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 959 - 964
  • [10] Pharmacological Approaches for Treatment-resistant Bipolar Disorder
    Poon, Shi Hui
    Sim, Kang
    Baldessarini, Ross J.
    [J]. CURRENT NEUROPHARMACOLOGY, 2015, 13 (05) : 592 - 604